Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312140952> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4312140952 endingPage "S31" @default.
- W4312140952 startingPage "S26" @default.
- W4312140952 abstract "The use of bispecific antibodies (BsAbs) in the treatment of relapsed/refractory multiple myeloma (MM) is showing early promising overall response rates in heavily pre-treated patients. Infectious complications related to the use of BsAbs are not well described. We conducted a pooled analysis that included all single agent BsAbs used in MM with no prior use of different BsAbs. A total of 1185 MM patients (number of trials, n=11) were treated with a BsAb in the studied period (71.6% of patients treated with an agent targeting B-cell maturation antigen (BCMA). Pooled median follow up was short at 6.1 months (7.5 vs. 5.2 months for BCMA vs. non-BCMA BsAbs, respectively). Adverse events (AEs) of interest included all grade neutropenia in 38.6% (n=441/1143), all grade infections in 50% (n=542/1083), all grade cytokine release syndrome (CRS) in 59.6% (n=706/1185), grade III/IV neutropenia in 34.8% (n=372/1068), grade III/IV infections in 24.5% (n=272/1110), grade III/IV pneumonia in 10% (n=52.4/506), and grade III/IV coronavirus 2019 (COVID-19) in 11.4% (n45.4/395). Non-BCMA targeted bispecific antibodies were associated with lower grade III/IV neutropenia (25.3% vs. 39.2%, P=0.001) and lower grade III/IV infections (11.9% vs. 30%, P=0.01) when compared to BCMA-targeted bispecific antibodies. Hypogammaglobulinemia was reported in 4 studies with prevalence of 75.3% (n=256/340) with intravenous immunoglobulin used in 48% (n=123/256). Death was reported in 110 patients of which 28 (25.5%) were reported to be secondary to infections. Certain precautions should be used when using BsAbs to mitigate the risk and/or identify and treat infections promptly." @default.
- W4312140952 created "2023-01-04" @default.
- W4312140952 creator A5023276777 @default.
- W4312140952 creator A5045179755 @default.
- W4312140952 creator A5058598134 @default.
- W4312140952 date "2023-05-01" @default.
- W4312140952 modified "2023-10-11" @default.
- W4312140952 title "Disparities in multiple myeloma among African Americans" @default.
- W4312140952 cites W1965661780 @default.
- W4312140952 cites W1966593373 @default.
- W4312140952 cites W2000150899 @default.
- W4312140952 cites W2012438857 @default.
- W4312140952 cites W2029204292 @default.
- W4312140952 cites W2036383379 @default.
- W4312140952 cites W2058827066 @default.
- W4312140952 cites W2063193300 @default.
- W4312140952 cites W2088551561 @default.
- W4312140952 cites W2146090874 @default.
- W4312140952 cites W2174854080 @default.
- W4312140952 cites W2345962463 @default.
- W4312140952 cites W2573302726 @default.
- W4312140952 cites W2590674004 @default.
- W4312140952 cites W2606117688 @default.
- W4312140952 cites W2611680298 @default.
- W4312140952 cites W2766415848 @default.
- W4312140952 cites W2768869002 @default.
- W4312140952 cites W2791941924 @default.
- W4312140952 cites W2871151515 @default.
- W4312140952 cites W2896055369 @default.
- W4312140952 cites W2911910338 @default.
- W4312140952 cites W2911979999 @default.
- W4312140952 cites W2937651819 @default.
- W4312140952 cites W2970171275 @default.
- W4312140952 cites W2998795209 @default.
- W4312140952 cites W3020978311 @default.
- W4312140952 cites W3044259272 @default.
- W4312140952 cites W3048024379 @default.
- W4312140952 cites W3089242107 @default.
- W4312140952 cites W3126876380 @default.
- W4312140952 cites W3131549382 @default.
- W4312140952 cites W82896988 @default.
- W4312140952 doi "https://doi.org/10.1016/j.jnma.2022.10.001" @default.
- W4312140952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36566137" @default.
- W4312140952 hasPublicationYear "2023" @default.
- W4312140952 type Work @default.
- W4312140952 citedByCount "0" @default.
- W4312140952 crossrefType "journal-article" @default.
- W4312140952 hasAuthorship W4312140952A5023276777 @default.
- W4312140952 hasAuthorship W4312140952A5045179755 @default.
- W4312140952 hasAuthorship W4312140952A5058598134 @default.
- W4312140952 hasBestOaLocation W43121409521 @default.
- W4312140952 hasConcept C126322002 @default.
- W4312140952 hasConcept C144024400 @default.
- W4312140952 hasConcept C149923435 @default.
- W4312140952 hasConcept C2776364478 @default.
- W4312140952 hasConcept C71924100 @default.
- W4312140952 hasConcept C74909509 @default.
- W4312140952 hasConceptScore W4312140952C126322002 @default.
- W4312140952 hasConceptScore W4312140952C144024400 @default.
- W4312140952 hasConceptScore W4312140952C149923435 @default.
- W4312140952 hasConceptScore W4312140952C2776364478 @default.
- W4312140952 hasConceptScore W4312140952C71924100 @default.
- W4312140952 hasConceptScore W4312140952C74909509 @default.
- W4312140952 hasIssue "2" @default.
- W4312140952 hasLocation W43121409521 @default.
- W4312140952 hasLocation W43121409522 @default.
- W4312140952 hasOpenAccess W4312140952 @default.
- W4312140952 hasPrimaryLocation W43121409521 @default.
- W4312140952 hasRelatedWork W1506200166 @default.
- W4312140952 hasRelatedWork W1995515455 @default.
- W4312140952 hasRelatedWork W2048182022 @default.
- W4312140952 hasRelatedWork W2080531066 @default.
- W4312140952 hasRelatedWork W2604872355 @default.
- W4312140952 hasRelatedWork W2748952813 @default.
- W4312140952 hasRelatedWork W2899084033 @default.
- W4312140952 hasRelatedWork W3031052312 @default.
- W4312140952 hasRelatedWork W3032375762 @default.
- W4312140952 hasRelatedWork W3108674512 @default.
- W4312140952 hasVolume "115" @default.
- W4312140952 isParatext "false" @default.
- W4312140952 isRetracted "false" @default.
- W4312140952 workType "article" @default.